Stockreport

Savara: Trial Successful, But I'm Only Half Convinced [Seeking Alpha]

Savara, Inc.  (SVRA) 
Last savara, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: savarapharma.com/investors/events-presentations
PDF Summary Savara's Molgramostim, a GM-CSF therapy, succeeded in a phase 3 trial for treating aPAP, a rare autoimmune lung condition, after a previous failure. The cur [Read more]